User talk:St3vo

From Wikipedia, the free encyclopedia

No problem - I figured it was something like that. -- Marj 18:41, 20 Oct 2004 (UTC)

Contents

[edit] Ohmefantanyl

Yeah I wasn't quite sure what to do about that. User:Nuklear had done a lot of work on various topics that I'm familiar with such as phenyltropane and fentanyl derivatives, but it got deleted from the main articles on the grounds that it was too complex for a general audience and much of it was plagarised. I was going to just rewrite the plagarised stuff to make it acceptable as he had included many good references and I felt the material added to wikipedia significantly, but since the consensus was that it was too complex for regular people to understand (which is stupid in my opinion since most people looking at these articles are likely to have an interest in neuropharmacology, structure-activity relationships etc) I felt that the best compromise was to leave the articles as short summaries and just link to the full articles which had been moved to his userspace. He got quite disheartened by having all his edits deleted and has now stopped editing so I guess its up to us to do something with. At the moment I've just been trying to go through and make pages for opioids and depressants that don't have pages at all yet, so it will be quite some time till I finish all those and get around to improving pages that already exist! But if you want to expand the ohmefentanyl page then go for it, I agree that its probably not appropriate for it to link to a page thats in userspace but if you look through the history of the pages on his userspace there's a lot of good material that would be entirely suitable once re-edited...Meodipt 10:58, 4 October 2007 (UTC)

[edit] Endocannabinoids

If you need help with the Ara-dopamine and Ara-glyceryl ether let me know. I'm working (in real life) in this area.

-- Panoramix303 (talk) 14:30, 21 November 2007 (UTC)

[edit] GPR55

If you have time it would be great if you could check the GPR55 article. I'm not a native english speaker, so your corrections are appreciated. -- Panoramix303 (talk) 13:48, 21 March 2008 (UTC)

[edit] Articles you might like to edit, from SuggestBot

SuggestBot predicts that you will enjoy editing some of these articles. Have fun!

Stubs
Cathine
SKF 38393
SCH 23390
Pemoline
Pergolide
Codeinone
Dihydrexidine
Dynorphin
Receptor (biochemistry)
Neuropharmacology
DRD4
Morphinone
Quinpirole
URB597
Pentazocine
SKF 82958
Fenoldopam
Norepinephrine transporter
Oxazepam
Cleanup
Oxycodone
Delirium tremens
Amobarbital
Merge
Depressant
Hydrochloride
Chromophil
Add Sources
Choline
Alicyclic compound
Dopamine reuptake inhibitor
Wikify
Omeprazole
Cellular neural network
ATM Adaptation Layer 5
Expand
Funafuti
Stimulus (physiology)
Electrophysiology

SuggestBot picks articles in a number of ways based on other articles you've edited, including straight text similarity, following wikilinks, and matching your editing patterns against those of other Wikipedians. It tries to recommend only articles that other Wikipedians have marked as needing work. Your contributions make Wikipedia better -- thanks for helping.

If you have feedback on how to make SuggestBot better, please tell me on SuggestBot's talk page. Thanks from ForteTuba, SuggestBot's caretaker.

P.S. You received these suggestions because your name was listed on the SuggestBot request page. If this was in error, sorry about the confusion. -- SuggestBot (talk) 22:42, 31 January 2008 (UTC)


[edit] 1-butyl-3-(1-naphthoyl)indole

This compound is also known as JWH-073 (Drug and Alcohol Dependence, 2000; 60:133–140).

I have written pages for some of the other more notable JWH compounds, as well as JWH-018, its 4-methoxy analogue JWH-081 is also worth a mention. There are of course heaps of other compounds from this family but many of them don't even have code numbers assigned, so are probably not notable enough to deserve their own pages yet. The pages are just stubs for now so could probably do with expanding further.Meodipt (talk) 06:18, 25 March 2008 (UTC)


[edit] SP-106

Hi St3vo. The compound SP-106, also known as Abbott 40656 was ultimately given the common name nabitan. If you can find out any more information about it then the page could certainly do with expanding, but there are so many other cannabinoid compounds of note that don't even have pages yet! I have expanded the cannabinoids template and put links to some of the compounds that seem to have been more widely used but will take a while to make pages for them all...Meodipt (talk) 12:34, 5 May 2008 (UTC)

[edit] Taranabant

Hi St3vo. Your structure for taranabant is incorrect, the nitrile group is the wrong way round (should be -C≡N not -N+≡C-). I'm not sure how to replace the image as it is from wikimedia commons and doesn't give me an option to upload a new version, but it would be good if you could upload a correct version. Nice find by the way, I hadn't come across that compound myself! Meodipt (talk) 03:55, 7 May 2008 (UTC)


Yeah the CB1 inverse agonists seem to have too harsh a side effect profile to be much good as anorectics judging by the post-marketing results from rimonabant, although perhaps they might show more promise as anti-addictive drugs. I suspect weak partial agonists at CB1 will be an area we will see much more growth in though, especially for applications like treating neuropathic pain that neither traditional opoids or NSAIDs deal with effectively. Lots of potential in this area for sure! Meodipt (talk) 09:40, 7 May 2008 (UTC)